Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis

BSE1667.156.55 (+0.39 %)

PREV CLOSE ( ) 1660.60

OPEN PRICE ( ) 1601.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1148

TODAY'S LOW / HIGH ( )1601.05 1682.95

52 WK LOW / HIGH ( )1383.7 2306.85

NSE1669.406.2 (+0.37 %)

PREV CLOSE( ) 1663.20

OPEN PRICE ( ) 1625.00

BID PRICE (QTY) 1669.40 (24)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26368

TODAY'S LOW / HIGH( ) 1625.00 1681.70

52 WK LOW / HIGH ( )1315 2318.3

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000

Management Info

Sushil Shah - Chairman Ameera Shah - Managing Director

Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

07Apr Metropolis Healthcare’s arm to acquire
Metropolis Healthcare’s wholly owned subsidiary -- Metropolis Histoxpert..

07Apr Metropolis Healthcare informs about di
Pursuant to Regulation 30 of the Listing Regulations, Metropolis Healthc..

28Mar Metropolis Healthcare informs about di
Metropolis Healthcare has informed that the exchange has received the di..

24Mar Metropolis Healthcare acquires Core Di
Metropolis Healthcare has completed the acquisition of Core Diagnostics..

24Mar Metropolis Healthcare rises on acquiri
Metropolis Healthcare is currently trading at Rs. 1611.15, up by 14.70 p..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	274.05	1158.9
Gross Profit	368.01	1574.09
Operating Profit	681.34	2704.78
Net Sales	2968.81	11034.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 4000.85 (1.05%)	M.Cap ( in Cr)1880.40
Thyrocare Tech. (BSE) 939.65 (3.53%)	M.Cap ( in Cr)4979.53
Max Healthcare Inst (BSE) 1126.95 (1.50%)	M.Cap ( in Cr)109555.55
RainbowChildrenS Med (BSE) 1346.45 (0.47%)	M.Cap ( in Cr)13673.43
Artemis Medicare (BSE) 240.05 (1.54%)	M.Cap ( in Cr)3335.07

Shareholding Pattern

	PROMOTERS	48.9%
	MUTUAL FUNDS/UTI	26.42%
	NON-INSTITUTION	5.52%
	FI/BANKS/INSURANCE	3.75%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
NJ ELSS Tax Saver S...	3.25
HDFC Pharma and Hea...	2.26
LIC MF Healthcare F...	2.23
HDFC Focused 30 Fund(G)	1.54
UTI Healthcare Fund...	1.50
Tata Business Cycle...	1.44
Baroda BNP Paribas ...	1.35

Risk Disclosures on Derivatives

Smart Quotes

METROPOLIS HEALTHCARE LTD.